Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Discover Weekly Automatic Buy Dividend Aristocrats Etf to set up a disciplined, recurring purchase schedule that smooths classic market timing.
14,755 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Rocket Lab’s stock has faced renewed pressure as the market weighs contracting demand signals and execution risks. Th...
CoreWeave is expanding fast on the AI cloud frontier, but heavy borrowing and rising interest expenses are pulling th...
A CFO's share sale coincides with bold guidance and a explosive stock rally. This look at what this butterfly network...
Jaguar Land Rover is recalling roughly 2,300 US-registered I-Pace electric SUVs due to a high-voltage battery fire ri...
A bold move from a top capital allocator signals a value tilt even in growth-beat markets. Explore Ackman’s strategy,...
A single housing metric has crossed a major milestone, signaling potential changes in loan access and affordability. ...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
EPAM Systems sank this week after reporting earnings that beat the street but offered cautious 2026 guidance. This ar...
In 2026, California's counties with highest property taxes are seeing bills rise as high-valued homes push costs up, ...
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...